Accelerated Radical Radiotherapy for Non-small Cell Lung Cancer using Two Common Regimens: a Single-centre Retrospective Study of Outcome

Clinical Oncology

Volumn 21, Issue 3, 2009, Pages 161-167

  Pemberton, L S ^a   Din, O S ^a   Fisher, P M ^a   Hatton, M Q ^a  

^a WESTON PARK HOSPITAL   (United Kingdom)

Author keywords

Acceleration; CHART; hypofractionation; non small cell lung cancer; radiotherapy

Indexed keywords

ACCELERATED HYPOFRACTIONATED RADIOTHERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; REPRODUCIBILITY; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 61549084024     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.11.016     Document Type: Article

References (25)

1. Rowell N.P., and Williams C.J. Radical radiotherapy for stage 1/2 non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev 2 (2001)
2. Free C.M., Ellis M., Beggs L., et al. Lung cancer outcomes at a UK cancer unit between 1998-2001. Lung Cancer (2007) 2007 [Epub ahead of print]
3. Pfister D.G., Johnson D.H., Azzoli C.G., et al. American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol 22 (2004) 330-353
4. Saunders M., Dische S., Barrett A., et al. Continuous, hyperfractionated, accelerated (CHART) vs conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. Radiother Oncol 52 (1999) 137-148
5. Panakis N., Gonsalves A., and Brada M. Technical aspects of radiotherapy for non-small cell lung cancer (NSCLC); a national survey of practice. Clin Oncol 17 (2007) S42
6. Withers H.R., Taylor J.M., and Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27 (1988) 131-146
7. Maciejewski B., Withers H.R., Taylor J.M.G., et al. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumour dose-response and repopulation. Int J Radiat Oncol Biol Phys 16 (1989) 831-843
8. Saunders M., Dische S., Barrett A., et al. Continuous hyperfractionated accelerated radiotherapy (CHART) vs conventional radiotherapy in non-small cell lung cancer: a randomised multi-centre trial. Lancet 350 (1997) 161-165
9. Clenton S.J., Fisher P.M., Conway J., et al. The use of lung dose-volume histograms in predicting post-radiation pneumonitis after non-conventionally fractionated radiotherapy for thoracic carcinoma. Clin Oncol 17 (2005) 599-603
10. Delaney G., Barton M., Jacob S., et al. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol 4 (2003) 120-128
11. Senan S., Burgers S., and Samson M.J. Can elective nodal irradiation be omitted in stage 3 non-small cell lung cancer? Analysis of recurrences in a phase 2 study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 54 (2002) 999-1006
12. Cheung P.C., Mackillop W.J., Dixon P., et al. Involved-field radiotherapy alone for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 48 (2000) 703-710
13. McGibney C., Holmberg O., McClean B., et al. Dose escalation of CHART in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary?. Int J Radiat Oncol Biol Phys 45 (1999) 339-350
14. Rosenweig K.E., Sim S.E., and Mychalczak B. Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 681-685
15. Bradley J.D., Wahab S., Lockett M.A., et al. Elective nodal failures are uncommon in medically inoperable patients with stage 1 non-small cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys 56 (2003) 342-347
16. Lester J.F., Macbeth F.R., Brewster A.E., et al. CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancer. Lung Cancer 45 (2004) 237-242
17. Faria S.L., Souhami L., Portelance L., et al. Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer. Radiat Oncol 1 (2006) 42
18. Graham M.V., and Purdy J.A. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
19. Le Chevalier J. 12th World Conference on Lung Cancer, Seoul, 2007.
20. Willner J., Baier K., Caragiani E., et al. Dose, volume, and tumor control prediction in primary radiotherapy of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 382-389
21. Saunders M.I., Rojas A., Lyn B.E., et al. Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small cell lung cancer. Br J Cancer 78 (1998) 1328-1338
22. Le Chevalier J., Arriagada R., Quoix E., et al. Radiotherapy alone vs combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer Suppl 1 (1994) S239-S244
23. Bradley J., Graham M.V., and Winter K. Toxicity and outcome results of RTOG 9311: a phase 1-2 dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
24. Uematsu M., Shioda A., Suda A., et al. Computer tomography-guided frameless stereotactic radiotherapy for stage 1 non-small cell lung cancer: a five year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
25. Fang L.C., Kamaki R., and Allen P. Comparison of outcomes for patients with medically inoperable stage 1 non-small cell lung cancer treated with two-dimensional vs three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 108-116